Septerna appoints Rajiv Patni, M.D., as Chief Medical Officer, effective Aug 24, 2026

Septerna, Inc.

Rajiv Patni, M.D., named CMO effective August 24, 2026; announcement press release dated August 25, 2026.
Patni brings 25+ years in biopharma; joins from Judo Bio where he was CEO, previously CRO at Reata.
He was CMO at Global Blood Therapeutics, Portola, Adamas, and Actelion; contributed to 10 regulatory approvals.
CEO Jeffrey Finer: Patni's experience will help advance Septerna's GPCR oral medicine pipeline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.